Hamamatsu Photonics and Sirona Dx Form Strategic Alliance
Hamamatsu Photonics Partners with Sirona Dx to Advance Technology Access
Hamamatsu Photonics, a renowned leader in whole slide imaging and spatial proteomics solutions, has initiated a strategic alliance with Sirona Dx (SDX). This exciting collaboration aims to optimize the technology evaluation process, providing researchers with needed access to in-depth spatial biology proficiency.
Streamlining Testing and Evaluation
The pace of innovation in spatial proteomics has prompted researchers and laboratories to encounter various challenges in assessing new technologies. Many face complexities regarding sample preparation, imaging, and staining. To alleviate these barriers, Hamamatsu has rolled out its Technology Access Program (TAP), allowing potential users to evaluate MoxiePlex Systems easily. This program eliminates the need for researchers to manage aspects like staining workflows and bioinformatics analysis during the assessment.
The Role of Sirona Dx
As a key collaborator, Sirona Dx brings extensive expertise in spatial omics and technology validation. This partnership is designed to bridge any knowledge gaps that may hinder product evaluation for customers. With both organizations joining forces, researchers can find a seamless way to experience Hamamatsu's technology in a compliant laboratory setting.
Key Benefits of the Partnership
The collaboration between Hamamatsu and SDX is set to offer a multitude of advantages:
- **Seamless Technology Access:** Customers can evaluate Hamamatsu's advanced spatial proteomics technology in a regulatory-compliant lab without worrying about sample preparation and data workflow.
- **Versatility:** The partnership caters to a diverse array of applications spanning research, clinical, and pharmaceutical realms.
Expert Insights
James Butler, the VP of Marketing at Hamamatsu Corporation, expressed enthusiasm about this partnership, stating, "This collaboration with SDX enhances our capability to assist customers in evaluating spatial proteomics solutions. By merging our cutting-edge imaging technology with SDX's expertise, we are facilitating a smoother experience for researchers and clinicians alike. The goal is to eliminate operational hurdles, paving the way for effective evaluations."
On the other side, Andrew Brown, Chief Commercial Officer at Sirona Dx, highlighted the importance of MoxiePlex technology. He stated, "We are thrilled about our partnership with Hamamatsu as it helps make powerful multiplex spatial imaging technology more accessible to clinical decision-makers. Our innovative design focuses on maximizing clinical utility by pushing the boundaries of precision and scalability, all while ensuring speed. This is a critical advancement for the industry."
About the Companies
Hamamatsu Photonics
Hamamatsu Photonics K.K. specializes in producing cutting-edge photonics devices, including cameras, light sources, optical sensors, and whole slide imaging systems, known for their reliability and precision.
Sirona Dx
Sirona Dx operates as a technical CRO, offering leading-edge single cell multi-omics and spatial biology services. The organization adeptly supports the design, optimization, and bioinformatics analysis essential for complex multi-analyte assays, significantly advancing biomarker discovery and therapy development.
Contact Information
If you're interested in updates regarding MoxiePlex or connecting directly with Sirona Dx about product engagement, reach out to:
Don Ariyakumar
MoxiePlex Strategic Product Manager
For additional queries, explore ways to connect during this transformative era in spatial proteomics.
Frequently Asked Questions
What is the purpose of the partnership between Hamamatsu and Sirona Dx?
The partnership aims to enhance the evaluation of spatial proteomics technologies, making them more accessible for researchers and clinicians.
What is the Technology Access Program (TAP)?
TAP is designed to facilitate the evaluation of MoxiePlex Systems without the complexities of staining workflows and data analysis.
What advantages does this partnership offer to researchers?
Researchers benefit from seamless access to advanced technology in a regulatory-compliant setting, alongside support for various applications.
Who are the key players in this collaboration?
The key players are Hamamatsu Photonics and Sirona Dx, with executives such as James Butler and Andrew Brown leading the initiative.
How can I contact the companies for more information?
You can reach out to Don Ariyakumar from Sirona Dx for inquiries related to MoxiePlex or the partnership offerings.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
